Internal Medicine
Antibody Tests Suggest that Coronavirus Infections Vastly Exceed Official Counts
20 Apr, 2020 | 00:25h | UTCAntibody tests suggest that coronavirus infections vastly exceed official counts – Nature
See original preprint study: COVID-19 Antibody Seroprevalence in Santa Clara County, California – medRxiv
Author interview: Dr. John Ioannidis Announces Results of COVID-19 Serology Study (video)
Other commentaries: Far more people may have been infected by coronavirus in one California county, study estimates – CNN AND The number of coronavirus infections in Santa Clara, California may be up to 85 times higher than testing shows, according to new research – Business Insider AND Up to 4% of Silicon Valley is already infected with coronavirus – MIT Technology Review
The Promise and Peril of Antibody Testing for COVID-19
20 Apr, 2020 | 00:23h | UTCThe Promise and Peril of Antibody Testing for COVID-19 – JAMA
See also: Will antibody tests for the coronavirus really change everything? – Nature AND Antibody Test, Seen as Key to Reopening Country, Does Not Yet Deliver – The New York Times AND With Broad, Random Tests for Antibodies, Germany Seeks Path out of Lockdown
How Does Coronavirus Kill?
20 Apr, 2020 | 00:21h | UTC
Review: COVID-19 and Thrombotic or Thromboembolic Disease
20 Apr, 2020 | 00:18h | UTC
The Science Underlying COVID-19: Implications for the Cardiovascular System
20 Apr, 2020 | 00:19h | UTCThe Science Underlying COVID-19: Implications for the Cardiovascular System – Circulation
Editorial: COVID-19 Pneumonia: ARDS or Not? – Critical Care
20 Apr, 2020 | 00:09h | UTCEditorial: COVID-19 pneumonia: ARDS or not? – Critical Care
Related: COVID-19 pneumonia: different respiratory treatment for different phenotypes? – Intensive Care Medicine AND Covid-19 Does Not Lead to a “Typical” Acute Respiratory Distress Syndrome – American Journal of Respiratory and Critical Care Medicine
Disruptive Modifications to Cardiac Critical Care Delivery During the Covid-19 Pandemic
20 Apr, 2020 | 00:14h | UTC
What’s Happening with Remdesivir?
20 Apr, 2020 | 00:12h | UTCWhat’s Happening With Remdesivir? – Science Translational Medicine
See also: Slow down your giddyup on Gilead news – Health News Review
Hospital Preparedness for COVID-19: A Practical Guide from a Critical Care Perspective
20 Apr, 2020 | 00:07h | UTC
The Pandemic’s Effects on Patients Without Covid-19
19 Apr, 2020 | 23:58h | UTC
Observational Study: Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Seems Safe Among Patients with Hypertension Hospitalized With COVID-19
20 Apr, 2020 | 00:01h | UTC
Systematic Review: Prophylactic Role of Chloroquine and Hydroxychloroquine in COVID‐19
19 Apr, 2020 | 23:57h | UTC
COVID-19 and Renin Angiotensin Blockers: Current Evidence and Recommendations
20 Apr, 2020 | 00:00h | UTCCOVID-19 and Renin Angiotensin Blockers: Current Evidence and Recommendations – Circulation
Commentary: COVID-19 and Renin Angiotensin Blockers – American College of Cardiology
Coronavirus: Nine in 10 Dying Have Existing Illness
17 Apr, 2020 | 02:20h | UTCCoronavirus: Nine in 10 dying have existing illness – BBC
Original Report: Deaths involving COVID-19, England and Wales: deaths occurring in March 2020 – Office for National Statistics
Study Commentary: Hydroxychloroquine Fails First Meaningful RCT
17 Apr, 2020 | 02:25h | UTCHydroxychloroquine fails first meaningful RCT – PulmCrit
Original Study: Hydroxychloroquine for Covid-19: No Benefit in New Open-label, Randomized Trial
Related Commentary: Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base – The Lancet Respiratory Medicine
Pathological Evidence of Pulmonary Thrombotic Phenomena in Severe COVID-19
17 Apr, 2020 | 02:24h | UTC* We congratulate the authors for this significant contribution to the understanding of this disease.
Meta-Analysis: Hematologic, Biochemical and Immune Biomarker Abnormalities Associated with Severe Illness and Mortality in COVID-19
17 Apr, 2020 | 02:22h | UTC“non-survivors compared to survivors had more significant increases in WBC count, total bilirubin, creatine kinase, serum ferritin, and interleukin 6 (IL-6), and more significant decreases in lymphocyte count and platelet count.”
CDC Guidance: Key Strategies to Prepare for COVID-19 in Long-term Care Facilities
17 Apr, 2020 | 02:18h | UTC
Innovation and Transformation in the Response to Covid-19: Seven Areas Where Clinicians Need to Lead
17 Apr, 2020 | 02:11h | UTC
Chest CT and Coronavirus Disease (COVID-19): A Critical Review of the Literature to Date
17 Apr, 2020 | 02:08h | UTC
Management of the Hospitalized COVID-19 Patient with Acute Cardiomyopathy or Heart Failure
17 Apr, 2020 | 02:05h | UTC
German Recommendations for Critically Ill Patients with COVID 19
17 Apr, 2020 | 02:02h | UTC
Review: Antidepressants for Irritable Bowel Syndrome
17 Apr, 2020 | 01:52h | UTCAntidepressants for irritable bowel syndrome – Canadian Family Physician
Neurologic Features in Severe SARS-CoV-2 Infection
16 Apr, 2020 | 02:56h | UTCNeurologic Features in Severe SARS-CoV-2 Infection – New England Journal of Medicine
Related Study: Neurologic Manifestations Common in Hospitalized Patients with Covid-19 (study and commentaries)
Pharyngitis: Approach to Diagnosis and Treatment
17 Apr, 2020 | 01:53h | UTCPharyngitis: Approach to diagnosis and treatment – Canadian Family Physician